Remote Monitoring of Patients With CHF in Central Greece

Summary

The purpose of this study is to evaluate whether telemonitoring of patients with chronic heart failure produces a reduction in the combined end point of all cause mortality and number of hospitalisations, and whether it improves health related quality of life. In addition, the trials evaluate the economic and organisational impact of the telemonitoring service and examine its acceptability by patients and health professionals.

Conditions

• Congestive Heart Failure

Interventions

PROCEDURE

Home telemonitoring of patients with CHF

Patients in the intervention group receive a personal 1-lead or 12-lead ECG recorder, a blood pressure monitor, a digital weight scale and appropriate education regarding the use of these devices. ThA trained nurse visits the patients weekly during the first month, and monthly thereafter, to confirm the appropriate use of the devices and services, to monitor symptoms, adherence to pharmacological and non-pharmacological treatment, and to complete the case record forms when necessary. If there is deterioration in the monitored vital signs, or if symptoms are reported, the allocated cardiologist is informed via the telehealth platform and has to decide whether the patient has to visit the hospital as in- or outpatient and whether the therapy has to be modified.

Sponsors & Collaborators

• Ministry for Health and Social Solidarity, Greece

  collaborator OTHER

• Municipality of Trikala, Greece

  collaborator OTHER

• Institute of Biomedical Research & Technology, Larissa, Greece

  collaborator OTHER

• Institute of Communications and Computer Systems, Athens, Greece

  collaborator OTHER

• Alexander Technological Educational Institute, Thessaloniki, Greece

  collaborator OTHER

• University of Macedonia, Thessaloniki, Greece

  collaborator OTHER

• University of Thessaly

  collaborator OTHER

• Regional Health Authority of Sterea & Thessaly

  lead OTHER_GOV

Principal Investigators

• Filippos Triposkiadis, MD, PhD · Cardiology Department - Regional University Hospital of Larisa

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2011-03-31

Primary Completion

2013-12-31

Completion

2014-01-31

Countries

• Greece

Study Locations